Editorial comments: treatment of motor fluctuations in Parkinson’s disease

Por Korczyn, Amos D.
Publicado em 2011

Drug treatment of Parkinson's disease

Por Korczyn, Amos D.
Publicado em 2004

Is dementia preventable?

Por Korczyn, Amos D.
Publicado em 2009

Editorial Comments: Is multiple sclerosis a neurodegenerative or inflammatory disease?

Por Korczyn, Amos D.
Publicado em 2013

What is new in vascular dementia?

Por Korczyn, Amos D.
Publicado no BMC Med (2016)

MATTERS ARISING: Inzelberg and Korczyn reply:

Por Inzelberg, Rivka, Korczyn, Amos D
Publicado em 1995

Mild cognitive impairment: Conceptual, assessment, ethical, and social issues

Por Werner, Perla, Korczyn, Amos D
Publicado em 2008

Can the disease course in Parkinson’s disease be slowed?

Por Korczyn, Amos D., Hassin-Baer, Sharon
Publicado no BMC Med (2015)

Vascular dementia

Por Korczyn, Amos D, Vakhapova, Veronika, Grinberg, Lea T
Publicado em 2012

Cerebral amyloid angiopathy impact on endothelium

Por Grinberg, Lea Tenenholz, Korczyn, Amos D., Heinsen, Helmut
Publicado em 2012

Biomarkers for prediction and targeted prevention of Alzheimer’s and Parkinson’s diseases: evaluation of drug clinical efficacy

Por Mandel, Silvia A., Morelli, Micaela, Halperin, Ilan, Korczyn, Amos D.
Publicado em 2010

Safety of phosphatidylserine containing omega-3 fatty acids in non-demented elderly: a double-blind placebo-controlled trial followed by an open-label extension

Por Vakhapova, Veronika, Richter, Yael, Cohen, Tzafra, Herzog, Yael, Korczyn, Amos D
Publicado em 2011

Disorders of the Oral Cavity in Parkinson's Disease and Parkinsonian Syndromes

Por Zlotnik, Yair, Balash, Yacov, Korczyn, Amos D., Giladi, Nir, Gurevich, Tanya
Publicado no Parkinsons Dis (2015)

Diabetes and the brain: issues and unmet needs

Por Bornstein, Natan M., Brainin, Michael, Guekht, Alla, Skoog, Ingmar, Korczyn, Amos D.
Publicado em 2014

A Randomised, Double-Blind, Placebo-Controlled Trial of Actovegin in Patients with Post-Stroke Cognitive Impairment: ARTEMIDA Study Design

Por Guekht, Alla, Skoog, Ingmar, Korczyn, Amos D., Zakharov, Vladimir, Eeg, Martin, Vigonius, Ulf
Publicado em 2013

Autonomic function in mice lacking α5 neuronal nicotinic acetylcholine receptor subunit

Por Wang, Ningshan, Orr-Urtreger, Avi, Chapman, Joab, Rabinowitz, Ruth, Nachman, Rachel, Korczyn, Amos D
Publicado em 2002

Biomarkers for evaluation of clinical efficacy of multipotential neuroprotective drugs for Alzheimer’s and Parkinson’s diseases

Por Halperin, Ilan, Morelli, Micaela, Korczyn, Amos D., Youdim, Moussa B. H., Mandel, Silvia A.
Publicado no Neurotherapeutics (2009)

MRI parameters of Alzheimer’s disease in an Arab population of Wadi Ara, Israel

Por Bowirrat, Abdalla, Reider-Groswasser, Irith I, Oscar-Berman, Marlene, Aizenstein, Orna, Levy, Gad, Korczyn, Amos D
Publicado em 2005

Unusual presentations in patients with E200K familial Creutzfeldt-Jakob Disease

Por Cohen, Oren S., Kimiagar, Itzhak, Korczyn, Amos D., Nitsan, Zeev, Appel, Shmuel, Hoffmann, Chen, Rosenmann, Hanna, Kahana, Esther, Chapman, Joab
Publicado no Eur J Neurol (2016)

Thalamo-striatal diffusion reductions precede disease onset in prion mutation carriers

Por Lee, Hedok, Rosenmann, Hanna, Chapman, Joab, Kingsley, Peter B., Hoffmann, Chen, Cohen, Oren S., Kahana, Esther, Korczyn, Amos D., Prohovnik, Isak
Publicado em 2009